ASND
Price
$227.87
Change
+$0.56 (+0.25%)
Updated
Oct 2 closing price
Capitalization
15.13B
40 days until earnings call
Intraday BUY SELL Signals
TARS
Price
$73.00
Change
-$2.46 (-3.26%)
Updated
Oct 2 closing price
Capitalization
3.59B
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASND vs TARS

ASND vs TARS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ASND vs. TARS commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a StrongBuy and TARS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ASND vs TARS: Fundamental Ratings
ASND
TARS
OUTLOOK RATING
1..100
5884
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
6822
SMR RATING
1..100
1294
PRICE GROWTH RATING
1..100
6140
P/E GROWTH RATING
1..100
82100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARS's Valuation (53) in the null industry is in the same range as ASND (76) in the Biotechnology industry. This means that TARS’s stock grew similarly to ASND’s over the last 12 months.

TARS's Profit vs Risk Rating (22) in the null industry is somewhat better than the same rating for ASND (68) in the Biotechnology industry. This means that TARS’s stock grew somewhat faster than ASND’s over the last 12 months.

ASND's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for TARS (94) in the null industry. This means that ASND’s stock grew significantly faster than TARS’s over the last 12 months.

TARS's Price Growth Rating (40) in the null industry is in the same range as ASND (61) in the Biotechnology industry. This means that TARS’s stock grew similarly to ASND’s over the last 12 months.

ASND's P/E Growth Rating (82) in the Biotechnology industry is in the same range as TARS (100) in the null industry. This means that ASND’s stock grew similarly to TARS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASNDTARS
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
70%
Bullish Trend 29 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 10 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (ASND: $227.31 vs. TARS: $75.46)
Brand notoriety: ASND and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 129% vs. TARS: 132%
Market capitalization -- ASND: $15.13B vs. TARS: $3.59B
ASND [@Biotechnology] is valued at $15.13B. TARS’s [@Biotechnology] market capitalization is $3.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 1 FA rating(s) are green while TARS’s FA Score has 1 green FA rating(s).

  • ASND’s FA Score: 1 green, 4 red.
  • TARS’s FA Score: 1 green, 4 red.
According to our system of comparison, TARS is a better buy in the long-term than ASND.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 5 TA indicator(s) are bullish while TARS’s TA Score has 4 bullish TA indicator(s).

  • ASND’s TA Score: 5 bullish, 5 bearish.
  • TARS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ASND is a better buy in the short-term than TARS.

Price Growth

ASND (@Biotechnology) experienced а -1.47% price change this week, while TARS (@Biotechnology) price change was -0.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

ASND is expected to report earnings on Nov 11, 2026.

TARS is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ASND
Daily Signal:
Gain/Loss:
TARS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKHAU12.790.29
+2.32%
Black Hawk Acquisition Corp
DECK79.571.43
+1.83%
Deckers Outdoor Corp
SRCE85.941.44
+1.70%
1st Source Corp
SPRY4.12-0.19
-4.41%
ARS Pharmaceuticals
ASPS6.17-0.52
-7.77%
Altisource Portfolio Solutions S.A.

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with ORMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-0.23%
ORMP - ASND
37%
Loosely correlated
-4.07%
AMRN - ASND
35%
Loosely correlated
-2.15%
AXON - ASND
34%
Loosely correlated
-0.07%
TARS - ASND
34%
Loosely correlated
-4.01%
BCYC - ASND
34%
Loosely correlated
-3.26%
More

TARS and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARS has been loosely correlated with IONS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARS
1D Price
Change %
TARS100%
-4.01%
IONS - TARS
40%
Loosely correlated
-1.46%
IMNM - TARS
38%
Loosely correlated
-2.88%
ARVN - TARS
37%
Loosely correlated
-3.94%
ARWR - TARS
36%
Loosely correlated
-1.01%
BLTE - TARS
36%
Loosely correlated
-4.03%
More